What is the primary mechanism of action for most antianxiety agents?

Correct answer: They cause generalized CNS depression.

Explanation

The fundamental action of most antianxiety medications, as described in the text, is to produce a generalized depression of the central nervous system (CNS), which leads to their anxiolytic effects.

Other questions

Question 1

Which class of antianxiety agents is generally considered more suitable for intermittent or short-term use?

Question 3

According to the text, what is a significant potential outcome of the long-term use of benzodiazepines?

Question 4

In which patient population is the use of antianxiety agents contraindicated?

Question 5

For which specific class of antianxiety agents does the text mention precautions related to severe underlying pulmonary disease?

Question 6

What is the potential interaction effect of taking benzodiazepines with alcohol or antihistamines?

Question 7

What vital signs are crucial to monitor frequently during the intravenous administration of antianxiety agents?

Question 8

When transitioning a patient to buspirone from another antianxiety agent, what is the recommended procedure for the previous medication?

Question 9

Which of the following is NOT listed as a long-term antianxiety agent?

Question 10

What is a characteristic that antianxiety agents do NOT possess?

Question 11

Antianxiety agents are contraindicated for use in patients with uncontrolled severe pain and which other condition?

Question 12

What is the recommended course of action regarding the dosage of antianxiety agents for patients with hepatic dysfunction?

Question 13

Concurrent use of antianxiety agents with which of the following drug classes should be avoided?

Question 14

What nursing assessment is critical for monitoring the therapeutic effect and side effects of antianxiety therapy?

Question 15

Why is it important to restrict the amount of antianxiety medication available to a depressed or suicidal patient?

Question 16

What is the primary reason for gradually decreasing the dose of a previous antianxiety agent when switching to buspirone?

Question 17

What is the key evaluation criterion for the effectiveness of antianxiety agent therapy?

Question 18

Which condition is a contraindication for the use of antianxiety agents?

Question 19

Besides antidepressants and opioid analgesics, which other drug class is mentioned to cause additive CNS depression when used with benzodiazepines?

Question 20

Slurred speech is mentioned as an indicator of what aspect of a patient's response to antianxiety therapy?

Question 21

What type of anxiety disorder is specifically mentioned in the 'General Use' section for antianxiety agents?

Question 22

During which two life stages is the use of antianxiety agents to be avoided?

Question 23

In addition to patients with hepatic dysfunction and severe renal impairment, in which patient group should benzodiazepines be used cautiously?

Question 24

What is a potential nursing diagnosis related to the side effects of antianxiety agents?

Question 25

Which statement about the properties of buspirone when switching medications is true?

Question 26

Which medication is identified as being suitable for long-term management of anxiety?

Question 27

What is a potential risk associated with prolonged high-dose therapy of antianxiety agents?

Question 28

Antianxiety agent use is contraindicated in patients with hypersensitivity, pre-existing CNS depression, and which other condition?

Question 29

Ataxia is a clinical sign used to assess what in a patient taking antianxiety agents?

Question 30

The potential nursing diagnosis 'Deficient knowledge' for a patient on antianxiety agents is related to what?

Question 31

Which of the following is an example of an antianxiety agent suitable for long-term use?

Question 32

Besides being comatose and having uncontrolled severe pain, what is another contraindication for using antianxiety agents?

Question 33

When are patients taking antianxiety agents considered more sensitive to CNS depressant effects, possibly requiring a lower dose?

Question 34

What is the primary evaluation outcome for a patient who has been on antianxiety medication?

Question 35

What is the general action of most agents in the antianxiety class?

Question 36

Which condition is listed as a contraindication for antianxiety agent therapy?

Question 37

A patient with a history of previous drug addictions is prescribed an antianxiety agent. What is the recommended approach?

Question 38

Additive CNS depression may occur when benzodiazepines are combined with which of the following?

Question 39

What is the rationale for assessing a patient's level of sedation using indicators like dizziness?

Question 40

Which of these is NOT a contraindication for the use of antianxiety agents?

Question 41

What is a potential risk that necessitates restricting the amount of an antianxiety drug available to a patient with a history of addiction?

Question 42

Which of the following agents is NOT suitable for short-term anxiety management?

Question 43

What is the primary interaction concern when most antianxiety agents are considered for use with MAO inhibitors?

Question 44

Prolonged high-dose therapy with antianxiety agents may lead to which of the following?

Question 45

Which patient population is identified as potentially being more sensitive to the CNS depressant effects of antianxiety agents?

Question 46

What is the primary management strategy for a patient with a history of addiction being treated with an antianxiety agent?

Question 47

Which of the following describes the therapeutic properties of antianxiety agents?

Question 48

For a patient receiving IV antianxiety medication, how often should BP, pulse, and respiratory status be monitored?

Question 49

The text advises using antianxiety agents with caution in patients who are suicidal or have had previous drug addictions. What other precaution is mentioned?

Question 50

What is the primary reason for a potential nursing diagnosis of 'Risk for injury' in a patient taking antianxiety agents?